Catch up growth in low birth weight infants: striking a healthy balance

Vandana Jain1, Atul Singhal

  • 1Division of Pediatric Endocrinology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. drvandanajain@gmail.com

Insights

Catch-up growth in infants born small for gestational age may increase later health risks. Balancing rapid growth with long-term health is crucial for Indian infants.

Area of Science:

  • Pediatrics
  • Public Health
  • Metabolic Health

Background:

  • Catch-up growth is common in infants born small for gestational age (SGA) and traditionally viewed positively.
  • Emerging evidence links rapid catch-up growth to increased risks of obesity, insulin resistance, and cardiovascular disease later in life.
  • India faces high rates of low birth weight (LBW) and infectious diseases, leading to policies promoting rapid infant growth.

Purpose of the Study:

  • To review the benefits and risks of catch-up growth in Indian infants.
  • To discuss the implications of rapid infant growth in the context of India's socio-economic transition and rising non-communicable diseases.
  • To highlight the need for a balanced approach to infant growth in India.

Main Methods:

  • Literature review and synthesis of existing research on infant growth, catch-up growth, and long-term health outcomes.
  • Analysis of the Indian context, including LBW rates, public health policies, and the changing obesogenic environment.
  • Discussion of the trade-offs between short-term growth benefits and potential long-term metabolic and cardiovascular risks.

Main Results:

  • Rapid catch-up growth, while addressing initial deficits, is associated with adverse long-term programming effects on body composition and metabolism.
  • India's current policies promoting rapid infant growth may conflict with the need to mitigate risks of obesity and type 2 diabetes in a transitioning environment.
  • The optimal growth trajectory for Indian infants, particularly those born LBW, remains uncertain, necessitating a nuanced approach.

Conclusions:

  • A critical balance is needed between promoting catch-up growth and preventing later-life metabolic and cardiovascular diseases in Indian infants.
  • Future policies should consider the long-term consequences of rapid infant weight gain in India's evolving socio-economic landscape.
  • Further research is needed to define optimal growth patterns for Indian infants to ensure healthy development and reduce the burden of non-communicable diseases.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...